{"id":34907,"date":"2024-03-06T12:00:00","date_gmt":"2024-03-06T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/pre-asthme-depistage-precoce-de-lasthme\/"},"modified":"2024-03-06T12:00:00","modified_gmt":"2024-03-06T12:00:00","slug":"pre-asthme-depistage-precoce-de-lasthme","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/fr\/news\/pre-asthme-depistage-precoce-de-lasthme\/","title":{"rendered":"Pr\u00e9-asthme : d\u00e9pistage pr\u00e9coce de l\u2019asthme"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--2606 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<p>L\u2019asthme est une maladie tr\u00e8s r\u00e9pandue qui touche entre 3 et 400 millions de personnes dans le monde. Pour beaucoup, il s\u2019agit d\u2019une maladie chronique \u00e0 vie, qui a de profondes r\u00e9percussions sur la qualit\u00e9 de vie. Pour d\u2019autres, elle peut \u00eatre mortelle. <\/p>\n<p>La charge li\u00e9e au traitement de l\u2019asthme est importante. Il n\u00e9cessite un traitement quotidien, une surveillance constante et de nombreux m\u00e9dicaments, notamment des inhalateurs, des corticost\u00e9ro\u00efdes oraux et, chez certains patients, des anticorps monoclonaux. Cependant, ceux-ci sont extr\u00eamement co\u00fbteux et tous les pays n\u2019en ont pas autoris\u00e9 l\u2019utilisation.  <\/p>\n<p>Il existe aujourd\u2019hui de nombreux facteurs de risque de l\u2019asthme, universellement reconnus. Mais il n\u2019existe pas de programmes de d\u00e9pistage syst\u00e9matique de l\u2019asthme chez les personnes \u00ab \u00e0 risque \u00bb. Si l\u2019on examine d\u2019autres affections qui pr\u00e9sentent des \u00ab pr\u00e9-\u00e9tats \u00bb d\u00e9finis, existe-t-il un \u00e9tat de \u00ab pr\u00e9-asthme \u00bb dans lequel nous pourrions intervenir afin d\u2019emp\u00eacher le d\u00e9veloppement d\u2019un asthme d\u00e9clar\u00e9 ?   <\/p>\n<p>Un article a \u00e9t\u00e9 publi\u00e9 dans Frontiers sur \u00ab<strong>Pr\u00e9-asthme : un concept utile pour la pr\u00e9vention et la modification de la maladie ? Un article d\u2019EUFOREA <\/strong>\u00bb, qui peut \u00eatre lu <a href=\"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2023.1291185\/full?&#038;utm_source=Email_to_authors_&#038;utm_medium=Email&#038;utm_content=T1_11.5e1_author&#038;utm_campaign=Email_publication&#038;field=&#038;journalName=Frontiers_in_Allergy&#038;id=1291185\" target=\"_blank\" rel=\"noopener\">ici<\/a>.<\/p>\n<p>Pour explorer cette question int\u00e9ressante, nous avons invit\u00e9 la professeure Glenis Scadding (membre du conseil d\u2019administration d\u2019EUFOREA et pr\u00e9sidente du groupe d\u2019experts d\u2019EUFOREA sur la rhinite) \u00e0 participer \u00e0 cette \u00e9mission d\u2019actualit\u00e9s d\u2019EUFOREA.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph paragraph--text-columns paragraph-id--2607 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<div class=\"video-container\"><center><iframe title=\"Lecteur vid\u00e9o YouTube\" src=\"https:\/\/www.youtube.com\/embed\/0yfuI1ScudM?si=M5sSKZ-AknAf-hFe?rel=0\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/center><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>L\u2019asthme est une maladie tr\u00e8s r\u00e9pandue qui touche entre 3 et 400 millions de personnes dans le monde. Pour beaucoup, il s\u2019agit d\u2019une maladie chronique \u00e0 vie, qui a de profondes r\u00e9percussions sur la qualit\u00e9 de vie. Pour d\u2019autres, elle peut \u00eatre mortelle. La charge li\u00e9e au traitement de l\u2019asthme est importante. Il n\u00e9cessite un traitement quotidien, une surveillance constante et de nombreux m\u00e9dicaments, notamment des inhalateurs, des corticost\u00e9ro\u00efdes oraux et, chez certains patients, des anticorps monoclonaux. Cependant, ceux-ci sont extr\u00eamement co\u00fbteux et tous les pays n\u2019en ont pas autoris\u00e9 l\u2019utilisation. Il existe aujourd\u2019hui de nombreux facteurs de risque de l\u2019asthme, universellement reconnus. Mais il n\u2019existe pas de programmes de d\u00e9pistage syst\u00e9matique de l\u2019asthme chez les personnes \u00ab \u00e0 risque \u00bb. Si l\u2019on examine d\u2019autres affections qui pr\u00e9sentent des \u00ab pr\u00e9-\u00e9tats \u00bb d\u00e9finis, existe-t-il un \u00e9tat de \u00ab pr\u00e9-asthme \u00bb dans lequel nous pourrions intervenir afin d\u2019emp\u00eacher le d\u00e9veloppement d\u2019un asthme d\u00e9clar\u00e9 ? Un article a \u00e9t\u00e9 publi\u00e9 dans Frontiers sur \u00abPr\u00e9-asthme : un concept utile pour la pr\u00e9vention et la modification de la maladie ? Un article d\u2019EUFOREA \u00bb, qui peut \u00eatre lu ici. Pour explorer cette question int\u00e9ressante, nous avons invit\u00e9 la professeure Glenis Scadding (membre du conseil d\u2019administration d\u2019EUFOREA et pr\u00e9sidente du groupe d\u2019experts d\u2019EUFOREA sur la rhinite) \u00e0 participer \u00e0 cette \u00e9mission d\u2019actualit\u00e9s d\u2019EUFOREA.<\/p>\n","protected":false},"author":1,"featured_media":34915,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[169],"tags":[171,172,284],"class_list":["post-34907","news","type-news","status-publish","has-post-thumbnail","hentry","category-emissions-dactualite-euforea","tag-actualites-euforea","tag-asthme","tag-publications"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.5 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Pr\u00e9-asthme : d\u00e9pistage pr\u00e9coce de l\u2019asthme - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/news\/pre-asthme-depistage-precoce-de-lasthme\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pr\u00e9-asthme : d\u00e9pistage pr\u00e9coce de l\u2019asthme\" \/>\n<meta property=\"og:description\" content=\"L\u2019asthme est une maladie tr\u00e8s r\u00e9pandue qui touche entre 3 et 400 millions de personnes dans le monde. Pour beaucoup, il s\u2019agit d\u2019une maladie chronique \u00e0 vie, qui a de profondes r\u00e9percussions sur la qualit\u00e9 de vie. Pour d\u2019autres, elle peut \u00eatre mortelle. La charge li\u00e9e au traitement de l\u2019asthme est importante. Il n\u00e9cessite un traitement quotidien, une surveillance constante et de nombreux m\u00e9dicaments, notamment des inhalateurs, des corticost\u00e9ro\u00efdes oraux et, chez certains patients, des anticorps monoclonaux. Cependant, ceux-ci sont extr\u00eamement co\u00fbteux et tous les pays n\u2019en ont pas autoris\u00e9 l\u2019utilisation. Il existe aujourd\u2019hui de nombreux facteurs de risque de l\u2019asthme, universellement reconnus. Mais il n\u2019existe pas de programmes de d\u00e9pistage syst\u00e9matique de l\u2019asthme chez les personnes \u00ab \u00e0 risque \u00bb. Si l\u2019on examine d\u2019autres affections qui pr\u00e9sentent des \u00ab pr\u00e9-\u00e9tats \u00bb d\u00e9finis, existe-t-il un \u00e9tat de \u00ab pr\u00e9-asthme \u00bb dans lequel nous pourrions intervenir afin d\u2019emp\u00eacher le d\u00e9veloppement d\u2019un asthme d\u00e9clar\u00e9 ? Un article a \u00e9t\u00e9 publi\u00e9 dans Frontiers sur \u00abPr\u00e9-asthme : un concept utile pour la pr\u00e9vention et la modification de la maladie ? Un article d\u2019EUFOREA \u00bb, qui peut \u00eatre lu ici. Pour explorer cette question int\u00e9ressante, nous avons invit\u00e9 la professeure Glenis Scadding (membre du conseil d\u2019administration d\u2019EUFOREA et pr\u00e9sidente du groupe d\u2019experts d\u2019EUFOREA sur la rhinite) \u00e0 participer \u00e0 cette \u00e9mission d\u2019actualit\u00e9s d\u2019EUFOREA.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/news\/pre-asthme-depistage-precoce-de-lasthme\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/pre-asthme-depistage-precoce-de-lasthme\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/pre-asthme-depistage-precoce-de-lasthme\\\/\",\"name\":\"Pr\u00e9-asthme : d\u00e9pistage pr\u00e9coce de l\u2019asthme - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/pre-asthme-depistage-precoce-de-lasthme\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/pre-asthme-depistage-precoce-de-lasthme\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/EUFOREA20News20Show20on20Pre-Asthma20Paper.png\",\"datePublished\":\"2024-03-06T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/pre-asthme-depistage-precoce-de-lasthme\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/news\\\/pre-asthme-depistage-precoce-de-lasthme\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/pre-asthme-depistage-precoce-de-lasthme\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/EUFOREA20News20Show20on20Pre-Asthma20Paper.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/EUFOREA20News20Show20on20Pre-Asthma20Paper.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/pre-asthme-depistage-precoce-de-lasthme\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/choisissez-votre-parcours\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Pr\u00e9-asthme : d\u00e9pistage pr\u00e9coce de l\u2019asthme\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pr\u00e9-asthme : d\u00e9pistage pr\u00e9coce de l\u2019asthme - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/news\/pre-asthme-depistage-precoce-de-lasthme\/","og_locale":"fr_FR","og_type":"article","og_title":"Pr\u00e9-asthme : d\u00e9pistage pr\u00e9coce de l\u2019asthme","og_description":"L\u2019asthme est une maladie tr\u00e8s r\u00e9pandue qui touche entre 3 et 400 millions de personnes dans le monde. Pour beaucoup, il s\u2019agit d\u2019une maladie chronique \u00e0 vie, qui a de profondes r\u00e9percussions sur la qualit\u00e9 de vie. Pour d\u2019autres, elle peut \u00eatre mortelle. La charge li\u00e9e au traitement de l\u2019asthme est importante. Il n\u00e9cessite un traitement quotidien, une surveillance constante et de nombreux m\u00e9dicaments, notamment des inhalateurs, des corticost\u00e9ro\u00efdes oraux et, chez certains patients, des anticorps monoclonaux. Cependant, ceux-ci sont extr\u00eamement co\u00fbteux et tous les pays n\u2019en ont pas autoris\u00e9 l\u2019utilisation. Il existe aujourd\u2019hui de nombreux facteurs de risque de l\u2019asthme, universellement reconnus. Mais il n\u2019existe pas de programmes de d\u00e9pistage syst\u00e9matique de l\u2019asthme chez les personnes \u00ab \u00e0 risque \u00bb. Si l\u2019on examine d\u2019autres affections qui pr\u00e9sentent des \u00ab pr\u00e9-\u00e9tats \u00bb d\u00e9finis, existe-t-il un \u00e9tat de \u00ab pr\u00e9-asthme \u00bb dans lequel nous pourrions intervenir afin d\u2019emp\u00eacher le d\u00e9veloppement d\u2019un asthme d\u00e9clar\u00e9 ? Un article a \u00e9t\u00e9 publi\u00e9 dans Frontiers sur \u00abPr\u00e9-asthme : un concept utile pour la pr\u00e9vention et la modification de la maladie ? Un article d\u2019EUFOREA \u00bb, qui peut \u00eatre lu ici. Pour explorer cette question int\u00e9ressante, nous avons invit\u00e9 la professeure Glenis Scadding (membre du conseil d\u2019administration d\u2019EUFOREA et pr\u00e9sidente du groupe d\u2019experts d\u2019EUFOREA sur la rhinite) \u00e0 participer \u00e0 cette \u00e9mission d\u2019actualit\u00e9s d\u2019EUFOREA.","og_url":"https:\/\/www.euforea.org\/news\/pre-asthme-depistage-precoce-de-lasthme\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","twitter_card":"summary_large_image","twitter_site":"@euforea","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/news\/pre-asthme-depistage-precoce-de-lasthme\/","url":"https:\/\/www.euforea.org\/news\/pre-asthme-depistage-precoce-de-lasthme\/","name":"Pr\u00e9-asthme : d\u00e9pistage pr\u00e9coce de l\u2019asthme - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/news\/pre-asthme-depistage-precoce-de-lasthme\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/news\/pre-asthme-depistage-precoce-de-lasthme\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/EUFOREA20News20Show20on20Pre-Asthma20Paper.png","datePublished":"2024-03-06T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/news\/pre-asthme-depistage-precoce-de-lasthme\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/news\/pre-asthme-depistage-precoce-de-lasthme\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/news\/pre-asthme-depistage-precoce-de-lasthme\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/EUFOREA20News20Show20on20Pre-Asthma20Paper.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/EUFOREA20News20Show20on20Pre-Asthma20Paper.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/news\/pre-asthme-depistage-precoce-de-lasthme\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/fr\/choisissez-votre-parcours\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/news\/"},{"@type":"ListItem","position":3,"name":"Pr\u00e9-asthme : d\u00e9pistage pr\u00e9coce de l\u2019asthme"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/#website","url":"https:\/\/www.euforea.org\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/34907","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/comments?post=34907"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/34907\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media\/34915"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media?parent=34907"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/categories?post=34907"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/tags?post=34907"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}